Found: 29
Select item for more details and to access through your institution.
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
- Published in:
- Nature Medicine, 2002, v. 8, n. 3, p. 225, doi. 10.1038/nm0302-225
- By:
- Publication type:
- Article
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine.
- Published in:
- Nature Medicine, 1999, v. 5, n. 6, p. 643, doi. 10.1038/9488
- By:
- Publication type:
- Article
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 317, doi. 10.3390/ijms22010317
- By:
- Publication type:
- Article
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 274, doi. 10.3390/vaccines8020274
- By:
- Publication type:
- Article
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 99, doi. 10.3390/vaccines7030099
- By:
- Publication type:
- Article
NKp44 expression, phylogenesis and function in non-human primate NK cells.
- Published in:
- International Immunology, 2009, v. 21, n. 3, p. 245, doi. 10.1093/intimm/dxn144
- By:
- Publication type:
- Article
Sequence Conservation and Antibody Cross-Recognition of Clade B Human Immunodeficiency Virus (HIV) Type 1 Tat Protein in HIV-1--nfected Italians, Ugandans, and South Africans.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 8, p. 1171
- By:
- Publication type:
- Article
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials.
- Published in:
- DNA & Cell Biology, 2002, v. 21, n. 9, p. 599, doi. 10.1089/104454902760330138
- By:
- Publication type:
- Article
Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0111360
- By:
- Publication type:
- Article
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100844
- By:
- Publication type:
- Article
Effect of MHC Haplotype on Immune Response upon Experimental SHIV<sub>SF162P4cy</sub> Infection of Mauritian Cynomolgus Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093235
- By:
- Publication type:
- Article
The HIV-1 Tat Protein Induces the Activation of CD8<sup>+</sup> T Cells and Affects <i>In Vivo</i> the Magnitude and Kinetics of Antiviral Responses.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0077746
- By:
- Publication type:
- Article
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048781
- By:
- Publication type:
- Article
Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013540
- By:
- Publication type:
- Article
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
- Published in:
- Springer Seminars in Immunopathology, 2006, v. 28, n. 3, p. 289, doi. 10.1007/s00281-006-0026-3
- By:
- Publication type:
- Article
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
- Published in:
- Archives of Virology, 2021, v. 166, n. 11, p. 2955, doi. 10.1007/s00705-021-05158-z
- By:
- Publication type:
- Article
Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection.
- Published in:
- Journal of Medical Primatology, 2001, v. 30, n. 4, p. 207, doi. 10.1034/j.1600-0684.2001.d01-54.x
- By:
- Publication type:
- Article
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.
- Published in:
- Journal of Medical Primatology, 2000, v. 29, n. 3/4, p. 193, doi. 10.1034/j.1600-0684.2000.290313.x
- By:
- Publication type:
- Article
Human CD38 interferes with HIV‐1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
- Published in:
- FASEB Journal, 2003, v. 17, n. 3, p. 1, doi. 10.1096/fj.02-0512fje
- By:
- Publication type:
- Article
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1704, doi. 10.3390/ijms25031704
- By:
- Publication type:
- Article
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Controlling Hiv-1: non-coding RnA gene therapy approaches to a functional cure.
- Published in:
- Frontiers in Immunology, 2015, p. 1, doi. 10.3389/fimmu.2015.00474
- By:
- Publication type:
- Article
Challenges in HIV vaccine research for treatment and prevention.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00417
- By:
- Publication type:
- Article
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
- Published in:
- European Journal of Immunology, 2003, v. 33, n. 6, p. 1548, doi. 10.1002/eji.200323954
- By:
- Publication type:
- Article
Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 12, p. 3546, doi. 10.1002/1521-4141(200112)31:12<3546::AID-IMMU3546>3.0.CO;2-W
- By:
- Publication type:
- Article
Enhanced follicular dendritic cell function in lymph nodes of simian immunodeficiency virus-infected macaques: Consequences for pathogenesis.
- Published in:
- European Journal of Immunology, 1997, v. 27, n. 12, p. 3214, doi. 10.1002/eji.1830271219
- By:
- Publication type:
- Article
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4<sup>+</sup> T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
- Published in:
- Retrovirology, 2016, v. 13, p. 1, doi. 10.1186/s12977-016-0261-1
- By:
- Publication type:
- Article
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
- Published in:
- Retrovirology, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12977-015-0151-y
- By:
- Publication type:
- Article